Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy

Clinical trial NCT01101399 · COMPLETED

Trial details

NCT number: NCT01101399
Sponsor: Vifor Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Iron-Deficiency Anemia

Start date: 2010-05-01
Primary completion: 2012-11-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.